These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4632467)

  • 1. Recall of acquired cellular resistance in mice by antigens from killed Brucella.
    Halliburton BL; Hinsdill RD
    Infect Immun; 1972 Jan; 5(1):42-7. PubMed ID: 4632467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
    Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
    Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Brucella abortus and Brucella melitensis infections of mice and their effect on acquired cellular resistance.
    Young EJ; Gomez CI; Yawn DH; Musher DM
    Infect Immun; 1979 Nov; 26(2):680-5. PubMed ID: 121113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface antigens of smooth brucellae.
    Diaz R; Jones LM; Leong D; Wilson JB
    J Bacteriol; 1968 Oct; 96(4):893-901. PubMed ID: 4176644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between macrophage migration inhibition and immunity to Brucella abortus in guinea-pigs.
    Cameron CM; Van Rensburg JJ; Engelbrecht MM
    Onderstepoort J Vet Res; 1976 Dec; 43(4):175-84. PubMed ID: 828715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.
    Pardon P; Marly J
    Ann Immunol (Paris); 1976; 127(1):57-70. PubMed ID: 821385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The virB-encoded type IV secretion system is critical for establishment of infection and persistence of Brucella ovis infection in mice.
    Sá JC; Silva TM; Costa EA; Silva AP; Tsolis RM; Paixão TA; Carvalho Neta AV; Santos RL
    Vet Microbiol; 2012 Sep; 159(1-2):130-40. PubMed ID: 22483850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serological comparison of complement fixation reactions using Brucella abortus and B. melitensis antigens in B. abortus infected cattle.
    Herr S; Lawrence JV; Brett OL; Ribeiro LM
    Onderstepoort J Vet Res; 1991 Jun; 58(2):111-4. PubMed ID: 1908965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunological properties of Brucella ribosomal preparations.
    Corbel MJ
    Dev Biol Stand; 1976; 31():115-22. PubMed ID: 816681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relationship of Brucella ovis to Brucella abortus and Brucella melitensis using the complement fixation test.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1969 Dec; 36(2):191-7. PubMed ID: 5005098
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization of brucella antigens that elicit a humoral immune response in Brucella abortus-infected cells.
    Schurig GG; Pringle AT; Breese SS
    Infect Immun; 1981 Dec; 34(3):1000-7. PubMed ID: 6800949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.
    Campos MA; Rosinha GM; Almeida IC; Salgueiro XS; Jarvis BW; Splitter GA; Qureshi N; Bruna-Romero O; Gazzinelli RT; Oliveira SC
    Infect Immun; 2004 Jan; 72(1):176-86. PubMed ID: 14688095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
    Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
    J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of antigens for complement fixation and gel diffusion tests in the diagnosis of infections caused by Brucella ovis and other Brucella.
    Myers DM; Jones LM; Varela-Diaz VM
    Appl Microbiol; 1972 May; 23(5):894-902. PubMed ID: 4624210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serological response to rough and smooth brucella antigens in cattle vaccinated with Brucella abortus strain 45/20 adjuvant vaccine.
    Corbel MJ; Bracewell CD
    Dev Biol Stand; 1976; 31():351-7. PubMed ID: 816691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro.
    Zhan Y; Cheers C
    Infect Immun; 1995 Feb; 63(2):720-3. PubMed ID: 7822049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.
    Stevens MG; Olsen SC; Palmer MV; Pugh GW
    Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.